Your institution may have access to this item. Find your institution then sign in to continue.
Title
RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
Authors
Brufsky, Adam M.; Hurvitz, Sara; Perez, Edith; Swamy, Raji; Valero, Vicente; O'Neill, Vincent; Rugo, Hope S.
Publication
Journal of Clinical Oncology, 2011, Vol 29, Issue 32, p4286